Abstract
A growing body of evidence suggests that malignancy often represents a failure of differentiation. Several model systems have been developed that show an inverse relationship between differentiation and malignancy. As tumor cells differentiate, they typically lose proliferative potential and the ability to cause tumors when implanted into susceptible hosts. Thus, an understanding of the cellular mechanisms of differentiation may yield insight into the mechanisms of the abnormal regulation of growth by cancer cells. Murine and human models of differentiation of tumor cells, including mouse erythroleukemia (MEL) cells, human leukemic cell lines, and mouse F9 teratocarcinoma cells, have been used to explore changes in the expression of important growth-regulated genes, such as cellular oncogenes and growth factors, as a function of differentiation induced in vitro. For example, a biphasic decline of c-myc and c-myb mRNA levels has been seen following dimethyl sulfoxide (DMSO) induction of MEL cells (Ramsey et al. 1986). Indeed, some authors have suggested a causal relationship between the downregulation of oncogene products and both differentiation and loss of malignancy. This has been supported by experiments showing that expression of transfected c-myc or c-myb genes into MEL cells blocks the induction of differentiation by DMSO (Dmitrovsky et al. 1986; Clarke et al. 1988). Differentiation of F9 cells can be induced by retinoic acid (RA) and dibutyryl cAMP and, as in MEL cells, is accompanied by specific changes in expression of protooncogenes, biochemical markers, developmentally active genes, and growth factors (reviewed in Miller et al. 1990a). These changes correlate with a decline in the malignant and proliferative potential of these differentiated cells (Strickland and Sawey 1980; Strickland and Mahdavi 1978).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrews PW (1988) Human teratocarcinomas. Biochim Biophys Acta 948: 17–36
Clarke MF, Kukowska-Latallo JF, Westin E, Smith M, Prochownik E (1988) Constitutive expression of a c-myb cDNA blocks friend murine erythroleukemia cell differentiation. Mol Cell Biol 8: 884–892
Dmitrovsky E, Kuehl WM, Hollis GF, Kirsch IR, Bender TP, Segal S (1986) Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukemia cell line. Nature 322: 748–750
Dmitrovsky E, Moy D, Miller WH Jr, Li A, Masui H (1990) Retinoic acid causes a decline in TGF-a expression, cloning efficiency, and tumorigenicity in a human embryonal cancer cell line. Oncogene Res 5: 233–239
Engström W, Rees AR, Heath JK (1985) Proliferation of a human embryonal carcinoma-derived cell line in serum-free medium: interrelationship between growth factor requirements and membrane receptor expression. J Cell Sci 73: 361–373
Finkelstein R, Weinberg R (1988) Differential regulation of N-myc expression in F9 teratocarcinoma cells. Oncogene Res 3: 287–292
Hauser CA, Joyner AL, Klein RD, Learned TK, Martin GR, Tjian R (1985) Expression of homologous homeo-box-containing genes in differentiated human teratocarcinoma cells and mouse embryos. Cell 43: 19–28
Hu L, Gudas LJ (1990) Cyclic AMP analogs and retinoic acid influence the expression of retinoic acid receptor a, ß, and gamma mRNAs in F9 teratocarcinoma cells. Mol Cell Biol 10: 391–396
Krust A, Kastner P, Petkovich M, Zelent A, Chambon P (1989) A third human retinoic acid receptor, hRAR-gamma. Proc Natl Acad Sci USA 86: 5310–5314
Melloni E, Pontremoli S, Michetti M, Sacco O, Cakiroglu AG, Jackson JF, Rifkind RA, Marks PA (1987) Protein kinase C activity and hexamethylene bisacetamide induced erythroleukemia cell differentiation. Proc Natl Acad Sci USA 84: 5282–5286
Miller WH Jr, Moy D, Li A, Grippo JF, Dmitrovsky E (1990a) Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line. Oncogene 5: 511–517
Miller WH Jr, Kurie J, Moy D, Lucas DA, Grippo JF, Masui H, Dmitrovsky E (1990b) Growth factor downregulation is linked to differentiation and loss of tumorigenicity in human teratocarcinoma cells. To be published
Ramsay RG, Ikeda K, Rifkind RA, Marks PA (1986) Changes in gene expression of erythroleukemia protooncogenes, globin genes, and cell division. Proc Natl Acad Sci USA 83: 6849–6853
Schofield PN, Engstrom W, Lee AJ, Biddle C, Graham CF (1987) Expression of cmyc during differentiation of the human teratocarcinoma line Tera-2. J Cell Sci 88: 57–64
Strickland S, Mandavi V (1978) The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15: 393–403
Strickland S, Sawey MJ (1980) Studies on the effect of retinoids on the differentiation of teratocarcinoma stem cells in vitro and in vivo. Dev Biol 78: 76–85
Wang S-Y, Gudas LJ (1983) Isolation of cDNA clones specific for collagen IV and laminin from mouse teratocarcinoma cells. Proc Natl Acad Sci USA 80: 5880–5884
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Miller, W.H., Dmitrovsky, E. (1991). Growth Factors in Human Germ Cell Cancer. In: Oosterhuis, J.W., Walt, H., Damjanov, I. (eds) Pathobiology of Human Germ Cell Neoplasia. Recent Results in Cancer Research, vol 123. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84485-0_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-84485-0_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84487-4
Online ISBN: 978-3-642-84485-0
eBook Packages: Springer Book Archive